HiSeq Sales Boost Illumina's Q3 Revenues, but Order Backlog Will Take Several Quarters to Fill
November 02, 2010
HiSeq Sales Boost Illumina's Q3 Revenues, but Order Backlog Will Take Several Quarters to Fill
The company is also updating its portfolio of sequencers: It launched the HiSeq 1000, reduced the list price for the GAIIx, and said it will discontinue the GAIIe.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Illumina Starts Shipping 600 Gb HiSeq Reagent Kits; Takes First Orders for MiSeq
May 3, 2011 / In Sequence - Illumina Sequencing Revenue Grows 70 Percent in Q4, Driven by HiSeq
February 15, 2011 / In Sequence - Stronger-than-Expected Demand for HiSeq Contributes to 50 Percent Boost in Sequencing Sales for Illumina in Q2
August 3, 2010 / In Sequence - Illumina Acquires Moleculo, Pre-announces Q4 Revenue Growth of 8 Percent
January 8, 2013 / GenomeWeb Daily News - Illumina's 21 Percent Increase in Q3 Revenue Driven by MiSeq, HiSeq 2500, Sequencing Services
October 29, 2012 / In Sequence